Home
Live Updates
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress : comparemela.com
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress
/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") will share new research during the 2022 American Society...
Related Keywords
China ,
Tokyo ,
Japan ,
United States ,
American ,
Kenji Yasukawa ,
Ahsan Arozullah ,
Enfortumab Vedotin ,
Erhan Berrak ,
Global Medical Affairs ,
American Society Of Clinical Oncology ,
Clevo ,
European Hematology Association ,
Astellas Pharma Inc ,
Head Of Development Therapeutic Areas ,
Prnewswire Astellas Pharma Inc ,
Medivation Inc ,
Clinical Oncology ,
Annual Meeting ,
Senior Vice President ,
Development Therapeutic Areas ,
Vice President ,
Poster Discussion ,
Genitourinary Cancer ,
Discussion Session ,
Poster Presentation ,
Gastrointestinal Cancer ,
Focus Area Approach ,
comparemela.com © 2020. All Rights Reserved.